The dextrans as vehicles for gene and drug delivery

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Zhang X, Huang G, Huang H. The glyconanoparticle as carrier for drug delivery. Drug Deliv. 25(1), 1840–1845 (2018). •• The glyconanoparticle as carrier for drug delivery is summarized.
  Medline CASGoogle Scholar
• 2. Zhang X, Huang G. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery. Drug Deliv. 24(2), 16–21 (2017). •• Synthetic lipoprotein as nanomaterial vehicle is used in the targeted drug delivery.
  Medline CASGoogle Scholar
• 3. Liu D, Bimbo LM, Mäkilä E et al. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. J. Control. Rel. 170(2), 268–278 (2013).
  Medline CASGoogle Scholar
• 4. Huang G, Huang H. Application of hyaluronic acid as carriers in drug delivery. Drug Deliv. 25(1), 766–772 (2018). •• The hyaluronic acid as carriers is applied in drug delivery.
  Medline CASGoogle Scholar
• 5. Härtner S, Kim HC, Hampp N. Phototriggered release of photolabile drugs via two‐photon absorption‐induced cleavage of polymer‐bound dicoumarin. J. Polym. Sci. Pol. Chem. 45(12), 2443–2452 (2010).
  Google Scholar
• 6. Huang G, Liu Y, Chen L. Chitosan and its derivatives as vehicles for drug delivery. Drug Deliv. 24(2), 108–113 (2017). •• Chitosan and its derivatives as vehicles for drug delivery are summarized.
  MedlineGoogle Scholar
• 7. Parchman ML, Zeber JE, Romero RR et al. Risk of coronary artery disease in Type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study. Med. Care 45(12), 1129–1134 (2007).
  MedlineGoogle Scholar
• 8. Huang S, Huang G. Preparation and drug delivery of dextran–drug complex. Drug Deliv. 26(1), 252–261 (2019).
  Medline CASGoogle Scholar
• 9. Appelhans D, Gumz H, Liu X et al. Photo-crosslinked hollow capsules as platform for biomedical applications. J. Control. Rel. 259, e26 (2017).
  Google Scholar
• 10. Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliver. Rev. 54(5), 715–758 (2002).
  Medline CASGoogle Scholar
• 11. Yuan YY, Mao CQ, Du XJ et al. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Adv. Mater. 24(40), 5476–5480 (2012).
  Medline CASGoogle Scholar
• 12. Tripathi SK, Goyal R, Gupta KC. Surface modification of crosslinked dextran nanoparticles influences transfection efficiency of dextran-polyethylenimine nanocomposites. Soft Matter 7(24), 11360–11371 (2011).
  CASGoogle Scholar
• 13. Togo Y, Takahashi K, Saito K et al. Aldehyded dextran and ε-poly(L-lysine) hydrogel as nonviral gene carrier. Stem Cells Int. 2013(9), 634379 (2013).
  MedlineGoogle Scholar
• 14. Meng C, Dong C, Zhu H et al. Biocompatible polyethylenimine-graft-dextran catiomer for highly efficient gene delivery assisted by a nuclear targeting ligand. Polym. Chem. 4(8), 2528–2539 (2013).
  Google Scholar
• 15. Kundu PP, Sharma V. Synthetic polymeric vectors in gene therapy. Curr. Opin. Solid State Mater. Sci. 12(5), 89–102 (2008). • The synthetic polymeric vectors in gene therapy are introduced.
  CASGoogle Scholar
• 16. Kutsevol NV, Chumachenko VA, Rawiso M et al. Star-like dextran-polyacrylamide polymers: prospects of use in nanotechnologies. J. Struct. Chem. 56(5), 959–966 (2015).
  CASGoogle Scholar
• 17. Wilson T. Passive and active role of fluorescers in the chemiluminescence of tetramethoxydioxetane. Photochem. Photobiol. 30(1), 177–183 (2010).
  Google Scholar
• 18. Jingting C, Yangde Z, Yi Z et al. Heparanase expression correlates with metastatic capability in human choriocarcinoma. Gynecol. Oncol. 107(1), 22–29 (2007).
  MedlineGoogle Scholar
• 19. Liu H, Yi Z, Tang D et al. Inhibition of choriocarcinoma by Fe₃O₄-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase. Int. J. Nanomed. 8(1), 4371–4377 (2013).
  MedlineGoogle Scholar
• 20. Li Q, Wang H, Ye S et al. Induction of apoptosis and inhibition of invasion in choriocarcinoma JEG-3 cells by α-calendic acid and β-calendic acid. Prostag. Leukotr. Ess. Fatty Acids 89(5), 367–376 (2013).
  Medline CASGoogle Scholar
• 21. Albert K, Eggimann GA, Jean-Louis R et al. Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure–activity relationships highlight the role of charge distribution across dendrimer generations. ACS Nano 7(5), 4668–4682 (2013).
  MedlineGoogle Scholar
• 22. Knorr V, Ogris M, Wagner E. An acid sensitive ketal-based polyethylene glycol-oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity. Pharm. Res. 25(12), 2937–2945 (2008).
  MedlineGoogle Scholar
• 23. Tang Q, Cao B, Lei X et al. Dextran-peptide hybrid for efficient gene delivery. Langmuir 30(18), 5202–5208 (2014).
  Medline CASGoogle Scholar
• 24. Situ JQ, Ye YQ, Zhu XL et al. Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells. Int. J. Nanomed. 2015, 665–675 (2015).
  Google Scholar
• 25. Parmar AR, Trivedi PP, Jena GB. Dextran sulfate sodium-induced ulcerative colitis leads to testicular toxicity in mice: role of inflammation, oxidative stress and DNA damage. Reprod. Toxicol. 49, 171–184 (2014).
  Medline CASGoogle Scholar
• 26. And WCT, Jong CM. Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules 4(5), 1277–1284 (2003).
  MedlineGoogle Scholar
• 27. Zhu L, Mahato RI. Lipid and polymeric carrier-mediated nucleic acid delivery. Expert Opin. Drug Deliv. 7(10), 1209–1226 (2010). • Lipid and polymeric carrier are mediated for nucleic acid delivery.
  Medline CASGoogle Scholar
• 28. Nalluri SK, Bultema JB, Boekema EJ et al. Photoresponsive molecular recognition and adhesion of vesicles in a competitive ternary supramolecular system. Chemistry 17(37), 10297–10303 (2011).
  Medline CASGoogle Scholar
• 29. Chen Z, Krishnamachary B, Bhujwalla ZM. Degradable dextran nanopolymer as a carrier for choline kinase (ChoK) siRNA cancer therapy. Nanomaterials 6(2), E34 (2016).
  MedlineGoogle Scholar
• 30. Zhang W, Li C, Jin Y et al. Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy. Drug Deliv. 25(1), 611–622 (2018).
  Medline CASGoogle Scholar
• 31. Luo C, Wang Y, Chen Q et al. Advances of paclitaxel formulations based on nanosystem delivery technology. Mini-Rev. Med. Chem. 12(5), 434–444 (2012).
  Medline CASGoogle Scholar
• 32. Stefanello TF, Couturaud B, Szarpak-Jankowska A et al. Coumarin-containing thermoresponsive hyaluronic acid-based nanogels as delivery systems for anticancer chemotherapy. Nanoscale 9(33), 12150–12162 (2017).
  Medline CASGoogle Scholar
• 33. Zu Y, Dan W, Zhao X et al. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles. Int. J. Mol. Sci. 12(7), 4237–4249 (2011).
  Medline CASGoogle Scholar
• 34. Shi K, Li C, He B. Studies on the toxic effects of magnetic targeting adriamycin-carboxymethyldextran magnetic nanoparticles. J. Biomed. Eng. 20(2), 219–221 (2003).
  CASGoogle Scholar
• 35. Peng K, Tomatsu I, Kros A. Light controlled protein release from a supramolecular hydrogel. Chem. Commun. 46(23), 4094–4096 (2010).
  Medline CASGoogle Scholar
• 36. Burova TV, Grinberg NV, Tur DR et al. Ternary interpolyelectrolyte complexes insulin-poly(methylaminophosphazene)-dextran sulfate for oral delivery of insulin. Langmuir 29(7), 2273–2281 (2013).
  Medline CASGoogle Scholar
• 37. Xie M, Fan D, Zhao Z et al. Nano-curcumin prepared via supercritical: improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int. J. Pharm. 496(2), 732–740 (2015).
  Medline CASGoogle Scholar
• 38. Gupta V, Aseh A, Ríos CN et al. Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int. J. Nanomed. 4(1), 115–122 (2009).
  Medline CASGoogle Scholar
• 39. Yousefpour P, Atyabi F, Vasheghani FE et al. Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations. Int. J. Nanomed. 6(6), 1487–1496 (2011).
  Medline CASGoogle Scholar
• 40. Shi S, Han L, Deng L et al. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression. J. Control. Rel. 194, 228–237 (2014).
  Medline CASGoogle Scholar
• 41. Deng X, Yin Z, Zhou Z et al. Carboxymethyl dextran-stabilized polyethyleneimine-poly(epsilon-caprolactone) nanoparticles-mediated modulation of microRNA-34a expression via small-molecule modulator for hepatocellular carcinoma therapy. ACS Appl. Mater. Inter. 8(27), 17068–17079 (2016).
  Medline CASGoogle Scholar
• 42. Han HS, Lee M, An JY et al. pH-responsieve carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy. J. Biomed. Mater. Res. Part B Appl. Biomater. 104(4), 789–796 (2015).
  MedlineGoogle Scholar
• 43. Zhang J, Zhao X, Chen Q et al. Systematic evaluation multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Acta Biomater. 50, 381–395 (2017).
  Medline CASGoogle Scholar
• 44. Niu X, Zhang Z, Zhong Y. Hydrogel loaded with self-assembled dextran sulfate–doxorubicin complexes as a delivery system for chemotherapy. Mater. Sci. Eng. C 77, 888–894 (2017).
  Medline CASGoogle Scholar
• 45. Liu P, Situ JQ, Li WS et al. High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy. Nanomed. Nanotechnol. Biol. Med. 11(4), 855–866 (2015).
  Medline CASGoogle Scholar
• 46. Hu Y, He L, Ding J et al. One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy. Carbohydr. Polym. 144, 223–229 (2016).
  Medline CASGoogle Scholar
• 47. Liu J, Qi C, Tao K et al. Sericin/dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment. ACS Appl. Mater. Inter. 8(10), 6411–6422 (2016).
  Medline CASGoogle Scholar
• 48. Fang JY, Al-Suwayeh SA. Nanoparticles as delivery carriers for anticancer prodrugs. Expert Opin. Drug Deliv. 9(6), 657–669 (2012).
  Medline CASGoogle Scholar
• 49. Pitarresi G, Casadei MA, Mandracchia D et al. Photocrosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery. J. Control. Rel. 119(3), 328–338 (2007). • The dextran and polyaspartamide derivatives are photocrosslinked to be suitable for colon-specific drug delivery.
  Medline CASGoogle Scholar
• 50. Varshosaz J, Emami J, Ahmadi F et al. Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis. J. Drug Target. 19(2), 140–153 (2011).
  Medline CASGoogle Scholar
• 51. Rai G, Yadav AK, Jain NK et al. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon. Drug Deliv. 23(1), 328–337 (2016).
  Medline CASGoogle Scholar
• 52. Scenario IT. What is the role of nanotechnology in diagnosis and treatment of metastatic breast cancer? Promising scenarios for the near future. J. Nanomater. 2016(5), 1–16 (2016).
  Google Scholar
• 53. Sun G, Mao JJ. Engineering dextran-based scaffolds for drug delivery and tissue repair. Nanomedicine 7(11), 1771–1784 (2012).
  Medline CASGoogle Scholar
• 54. Sverremark E, Fernandez C. Immunogenicity of bacterial carbohydrates. Cholera toxin improves the immune response to dextran B512. Immunology 92(1), 153–159 (2010).
  Google Scholar
• 55. Varshosaz J. Dextran conjugates in drug delivery. Expert Opin. Drug Deliv. 9(5), 509–523 (2012). • The dextran conjugates are used in drug delivery.
  Medline CASGoogle Scholar